- TheStreet.com•last month
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
- Capital Cube•2 months ago
Click here to see latest analysisNivalis Therapeutics, Inc. reports financial results for the quarter ended March 31, 2016.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD -7.84 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.NVLS-US‘s earnings and EBITDA are […] (Read more...) The post Nivalis Therapeutics, Inc. :NVLS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016 appeared first on CapitalCube.
|Ask||4.90 x 1000|
|52wk Range||3.68 - 20.43|
|Day's Range||4.55 - 4.85|
|Avg Vol (3m)||48,146|
As of 4:00 PM EDT. Market closed.